ロード中...
The kinase inhibitors dabrafenib and trametinib affect isolated immune cell populations
Metastatic melanoma is frequently fatal. Optimal treatment regimens require both rapid and durable disease control, likely best achieved by combining targeted agents with immunotherapeutics. In order to accomplish this, a detailed understanding of the immune consequences of the kinase inhibitors use...
保存先:
| 出版年: | Oncoimmunology |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4292757/ https://ncbi.nlm.nih.gov/pubmed/25610732 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.946367 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|